fms related receptor tyrosine kinase 4
Last updated 28 Jun 2022
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The FLT4 gene provides instructions for making a protein called vascular endothelial growth factor receptor 3 (VEGFR-3), which regulates the development and maintenance of the lymphatic system. The lymphatic system produces and transports fluids and immune cells throughout the body. VEGFR-3 is turned on (activated) by two proteins called vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D). When VEGF-C and VEGF-D attach (bind) to VEGFR-3, chemical signals are produced that regulate the growth, movement, and survival of lymphatic cells.
Video picks for GenesVideo library
Normal function
The FLT4 gene provides instructions for making a protein called vascular endothelial growth factor receptor 3 (VEGFR-3), which regulates the development and maintenance of the lymphatic system. The lymphatic system produces and transports fluids and immune cells throughout the body. VEGFR-3 is turned on (activated) by two proteins called vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D). When VEGF-C and VEGF-D attach (bind) to VEGFR-3, chemical signals are produced that regulate the growth, movement, and survival of lymphatic cells.
Conditions referring to this gene or chromosome
Other names
FLT41
fms-related tyrosine kinase 4
vascular endothelial growth factor receptor 3
VEGFR3
VGFR3_HUMAN
Patient picks for Genes

Heart health and blood vessels
Deep vein thrombosis
A deep vein thrombosis (DVT) is a blood clot in a vein. Blood clots in veins most often occur in the legs but can occur elsewhere in the body, including the arms. This leaflet is about blood clots in leg veins. The most common cause of a blood clot developing in a vein is immobility. A complication can occur in some cases where part of the blood clot breaks off and travels to the lung (pulmonary embolus). This is usually prevented if you are given anticoagulation treatment.
by Dr Toni Hazell, FRCGP

Travel and vaccinations
Zika virus
Zika virus was a rare illness before 2015 when a sudden outbreak in Brazil became the subject of international headlines. However, it has been at a relatively low level since 2018. You can catch Zika virus if you are bitten by an affected mosquito. Zika virus is usually a very mild illness. However, it is possibly the cause of birth defects in babies born to mothers who have the infection in pregnancy. It may also cause other complications. Concern about the possible link of these conditions with Zika virus led the World Health Organization (WHO) to declare it a public health emergency of international concern. Research on the prevention of Zika virus is ongoing.
by Dr Hayley Willacy, FRCGP

Travel and vaccinations
Altitude sickness
Altitude sickness can affect people who climb or travel (ascend) to more than 2500 metres (8,000 feet) altitude, particularly if they ascend too quickly.
by Dr Philippa Vincent, MRCGP

Chest and lungs
Tuberculosis
Tuberculosis (TB) is an infection with a germ (bacterium) called Mycobacterium tuberculosis. If you have symptoms, or a doctor can find signs of the infection when examining you, this is known as active tuberculosis. If you have TB infection without any signs or symptoms, this is known as latent TB.
by Dr Colin Tidy, MRCGP

Travel and vaccinations
Ebola
Ebola is a viral infection, which mainly occurs in West and Equatorial Africa. There is as yet no vaccine or cure for Ebola, and about 4 out of 10 of those infected die of the disease. The risk of becoming infected with Ebola in the UK is very small. Ebola is spread by close contact with an infected person. People with Ebola become infectious when they have symptoms.
by Dr Mary Elisabeth Lowth, FRCGP

Travel and vaccinations
Jet lag
Jet lag occurs after travelling rapidly across several time zones, because the body's internal clock has not adjusted to the required sleep-wake cycle in the new time zone. Jet lag causes physical and psychological symptoms, the severity of which increases with the number of time zones crossed and direction of travel. Eastward travel, when hours are 'gained' is associated with worse jet lag than westward travel, when hours are 'lost.'
by Dr Hayley Willacy, FRCGP
Related patient information and medicines

Patient information leaflet
Mouth cancer
Epidermal growth factor receptor monoclonal antibody (EGFR mAb) is one form of targeted therapy. Cetuximab is an EGFR mAb. Tyrosine kinase inhibitors (TKIs) are another. Immunotherapy is treatment that aims to boost the body's own immune system to destroy the cancer cells. It is also sometimes called biological therapy: Recombinant interleukin.

Patient information leaflet
Chronic myeloid leukaemia
Treatment for the initial chronic phase The aim of treatment is to control the disease process, to ease any symptoms and to prevent (or delay) the progress... You may be advised to have one or more of the following treatments: Imatinib tablets. This medicine is known as a tyrosine kinase inhibitor. The chemical tyrosine kinase is made by the.

Patient information leaflet
Mastocytosis and mast cell disorders
If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on ... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new guidance on the use of midostaurin for people with mastocytosis..

Patient information leaflet
Fibromyalgia
Fibromyalgia is a condition which causes pain and tenderness in the muscles and soft tissues in different areas of the body, associated with unrefreshing sleep and physical tiredness. The word fibromyalgia means pain (-algia) coming from the muscles (my-) and fibrous tissues (fibro-) such as tendons and ligaments. Due to its wide range of.

Patient information leaflet
Macular degeneration
It is more common with increasing age. It is rare under the age of 60. It usually begins in one eye. About 5 in 100 people aged over 65 and about 12 in 100 people aged over 80 have AMD severe enough to cause serious visual impairment. Women are more likely than men to develop AMD. White people are more likely to develop AMD than those of African.

Patient information leaflet
Liver function tests
They include substances that are made in the liver or affected by the health of the liver cells, chemicals which are processed or excreted by the liver, and hormones that the liver makes. What are liver function tests used for. Liver function tests are aimed at giving a picture of the 'state' of your liver. They are a sensitive way of looking for.
Further reading and references
- fms related receptor tyrosine kinase 4; MedlinePlus, National Library of Medicine.
- Brice G, Child AH, Evans A, Bell R, Mansour S, Burnand K, Sarfarazi M, Jeffery S, Mortimer P. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005 Feb;42(2):98-102. doi: 10.1136/jmg.2004.024802.
- Butler MG, Dagenais SL, Rockson SG, Glover TW. A novel VEGFR3 mutation causes Milroy disease. Am J Med Genet A. 2007 Jun 1;143A(11):1212-7. doi: 10.1002/ajmg.a.31703.
- Evans AL, Bell R, Brice G, Comeglio P, Lipede C, Jeffery S, Mortimer P, Sarfarazi M, Child AH. Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. J Med Genet. 2003 Sep;40(9):697-703. doi: 10.1136/jmg.40.9.697. No abstract available.
- Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet. 2000 Aug;67(2):295-301. doi: 10.1086/303019. Epub 2000 Jun 9.
- Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000 Jun;25(2):153-9. doi: 10.1038/75997.
- Van Zanten M, Mansour S, Ostergaard P, Mortimer P, Gordon K. Milroy Disease. 2006 Apr 27 [updated 2021 Feb 18]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1239/
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

